Developing Drugs to Decrease the Toxicity of Chemotherapy
作者： Grant Williams , Patricia Cortazar , Richard Pazdur , Gerald Batist , Lauri Welles
DOI: 10.1200/JCO.2001.19.14.3439
关键词:
摘要:
sci-hub.se 参考文章(4)
S M Swain, F S Whaley, M C Gerber, S Weisberg, M York, D Spicer, S E Jones, S Wadler, A Desai, C Vogel, J Speyer, A Mittelman, S Reddy, K Pendergrass, E Velez-Garcia, M S Ewer, J R Bianchine, R A Gams, Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer. Journal of Clinical Oncology. ,vol. 15, pp. 1318- 1332 ,(1997) , 10.1200/JCO.1997.15.4.1318
Martee L. Hensley, LynnM. Schuchter, Celeste Lindley, NealJ. Meropol, GaryI. Cohen, Gail Broder, WilliamJ. Gradishar, DanielM. Green, RobertJ. Langdon, R.Brian Mitchell, Robert Negrin, TedP. Szatrowski, J.Tate Thigpen, Daniel VonHoff, ToddH. Wasserman, EricP. Winer, DavidG. Pfister, American Society of Clinical Oncology Clinical Practice Guidelinesfor the Use of Chemotherapy and Radiotherapy Protectants Journal of Clinical Oncology. ,vol. 17, pp. 3333- 3355 ,(1999) , 10.1200/JCO.1999.17.10.3333
Gerald Batist, Gopal Ramakrishnan, Chandra Sekhar Rao, Aruna Chandrasekharan, John Gutheil, Troy Guthrie, Pankaj Shah, Ali Khojasteh, Madhavan Krishnan Nair, Karen Hoelzer, Katherine Tkaczuk, Youn Choi Park, Lily W. Lee, Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer Journal of Clinical Oncology. ,vol. 19, pp. 1444- 1454 ,(2001) , 10.1200/JCO.2001.19.5.1444
S M Swain, F S Whaley, M C Gerber, M S Ewer, J R Bianchine, R A Gams, Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy. Journal of Clinical Oncology. ,vol. 15, pp. 1333- 1340 ,(1997) , 10.1200/JCO.1997.15.4.1333